Abbott Laboratories (ABT) Asset Writedowns and Impairment (2016)

Abbott Laboratories has disclosed Asset Writedowns and Impairment across 1 years of filings, most recently posting $947.0 million for Q3 2016.

• In Q3 2016, Asset Writedowns and Impairment changed N/A year-over-year to $947.0 million; the TTM figure through Sep 2016 stood at $947.0 million (changed N/A YoY), while the FY2016 annual figure was $947.0 million, changed N/A from the prior year.
• Asset Writedowns and Impairment came in at $947.0 million for Q3 2016 at Abbott Laboratories.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $947.0 million in Q3 2016 to a low of $947.0 million in Q3 2016.